That’s 11 patients recruited thus far with 26 in total needed for 2A.
They expect to update the market in regards to efficacy in Q3/24 which sounds more realistic.
Ann: Update on ACCENT Trial in Pancreatic Cancer, page-2
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
20.3¢ |
Change
0.018(9.46%) |
Mkt cap ! $99.72M | |||
| Open | High | Low | Value | Volume |
| 19.0¢ | 20.5¢ | 19.0¢ | $741.8K | 3.739M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 15 | 549236 | 20.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 20.5¢ | 225143 | 7 |
View Market Depth
| Last trade - 14.02pm 08/08/2025 (20 minute delay) ? |
| ATX (ASX) Chart |